Business Context and Reporting Period
This Form 8-K filing by Amprius Technologies, Inc. (AMPX) is dated April 22, 2025, reporting events occurring on April 22 and April 23, 2025. The filing focuses on significant executive leadership changes and board appointments rather than periodic financial results.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. As a Current Report (Form 8-K), this document is limited to disclosing specific material events and does not contain comprehensive financial statements.
Material Changes
- Executive Appointment: Tom Stepien was appointed President, effective May 1, 2025.
- Board Election: Tom Stepien was elected as a Class I director, effective May 1, 2025, with a term expiring at the 2026 annual meeting.
- Leadership Structure: Dr. Kang Sun will continue to serve as Chief Executive Officer (CEO) while Mr. Stepien assumes the role of President.
Compensation, Outlook, and Risks
Compensation Arrangements
- Base Salary: $475,000 annually.
- Cash Bonus: Target amount of 70% of base salary, contingent on performance goals.
- Equity Grant: 400,000 restricted stock units (RSUs) granted May 1, 2025. Vesting schedule includes 25% after one year, with the remainder vesting quarterly over three years.
- Severance: Six months of base salary continuation if terminated without cause or for good reason, subject to a release of claims.
Management Commentary and Background
The Board cited Mr. Stepien's extensive experience in the battery and energy storage industries, including his prior roles as CEO of South 8 Technologies, Operating Partner at KCK Group, and co-founder of Primus Power. He holds 11 U.S. and international battery patents.
Risks and Contingencies
Employment is at-will and may be terminated by either party at any time. The filing references an indemnification agreement requiring the Company to cover certain legal expenses incurred by Mr. Stepien in his official capacity.
Investor Verification Checklist
- Verify the exact vesting schedule and performance metrics for the 400,000 RSU grant in the full Offer Letter (to be filed as an exhibit to the Q1 2025 Form 10-Q).
- Confirm the specific definition of "good reason" and "cause" within the employment agreement to understand severance triggers.
- Review the Company's upcoming Form 10-Q for the fiscal period ending March 31, 2025, for the complete text of the Offer Letter and any related financial impact.
- Monitor the transition period starting May 1, 2025, to assess the operational impact of the new President-CEO reporting structure.